BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8397824)

  • 21. Comparison of enzyme and DNA analysis in a Tay-Sachs disease carrier screening program.
    Yoo HW; Astrin KH; Desnick RJ
    J Korean Med Sci; 1993 Feb; 8(1):84-91. PubMed ID: 8343225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and molecular characterization of non-classic forms of Tay-Sachs disease in Brazil.
    Rozenberg R; Kok F; Burin MG; Sá Miranda MC; Vasques C; Henriques-Souza AM; Giugliani R; Vainzof M; Pereira LV
    J Child Neurol; 2006 Jun; 21(6):540-4. PubMed ID: 16948947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid detection of fetal Mendelian disorders: Tay-Sachs disease.
    Guetta E; Peleg L
    Methods Mol Biol; 2008; 444():147-59. PubMed ID: 18425478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-hexosaminidase splice site mutation has a high frequency among non-Jewish Tay-Sachs disease carriers from the British Isles.
    Landels EC; Green PM; Ellis IH; Fensom AH; Bobrow M
    J Med Genet; 1992 Aug; 29(8):563-7. PubMed ID: 1387685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A glycine250--> aspartate substitution in the alpha-subunit of hexosaminidase A causes juvenile-onset Tay-Sachs disease in a Lebanese-Canadian family.
    Trop I; Kaplan F; Brown C; Mahuran D; Hechtman P
    Hum Mutat; 1992; 1(1):35-9. PubMed ID: 1301189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and rapid detection of three Tay-Sachs mutations in the Moroccan Jewish population.
    Drucker L; Proia RL; Navon R
    Am J Hum Genet; 1992 Aug; 51(2):371-7. PubMed ID: 1322637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Val192Leu mutation in the alpha-subunit of beta-hexosaminidase A is not associated with the B1-variant form of Tay-Sachs disease.
    Hou Y; Vavougios G; Hinek A; Wu KK; Hechtman P; Kaplan F; Mahuran DJ
    Am J Hum Genet; 1996 Jul; 59(1):52-8. PubMed ID: 8659543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of beta-hexosaminidase A deficiency in Tay-Sachs disease.
    Okada S; O'Brien JS
    Adv Genet; 2001; 44():61-6. PubMed ID: 11596999
    [No Abstract]   [Full Text] [Related]  

  • 29. Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model.
    Kaback MM
    Eur J Pediatr; 2000 Dec; 159 Suppl 3():S192-5. PubMed ID: 11216898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.
    Akerman BR; Natowicz MR; Kaback MM; Loyer M; Campeau E; Gravel RA
    Am J Hum Genet; 1997 May; 60(5):1099-106. PubMed ID: 9150157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterozygosity for Tay-Sachs disease in non-Jewish Americans with ancestry from Ireland or Great Britain.
    van Bael M; Natowicz MR; Tomczak J; Grebner EE; Prence EM
    J Med Genet; 1996 Oct; 33(10):829-32. PubMed ID: 8933335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. At least six different mutations in HEXA gene cause Tay-Sachs disease among the Turkish population.
    Ozkara HA; Navon R
    Mol Genet Metab; 1998 Nov; 65(3):250-3. PubMed ID: 9851891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tay-Sachs disease with hexosaminidase A: characterization of the defective enzyme in two patients.
    Bayleran J; Hechtman P; Kolodny E; Kaback M
    Am J Hum Genet; 1987 Oct; 41(4):532-48. PubMed ID: 2959149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adenoviral vector-mediated gene transfer.
    Akli S; Guidotti JE; Vigne E; Perricaudet M; Sandhoff K; Kahn A; Poenaru L
    Gene Ther; 1996 Sep; 3(9):769-74. PubMed ID: 8875224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel HEXA mutation [1393G>A (D465N)] in a Mexican Tay-Sachs disease patient.
    Alvarez-Rodríguez A; Triggs-Raine B; Barros-Núñez P; Lozano CM
    Hum Mutat; 2001 May; 17(5):437. PubMed ID: 11317368
    [No Abstract]   [Full Text] [Related]  

  • 36. The molecular basis of Tay-Sachs disease: mutation identification and diagnosis.
    Mahuran DJ; Triggs-Raine BL; Feigenbaum AJ; Gravel RA
    Clin Biochem; 1990 Oct; 23(5):409-15. PubMed ID: 2147596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three novel beta-hexosaminidase A mutations in obligate carriers of Tay-Sachs disease.
    Tomczak J; Grebner EE
    Hum Mutat; 1994; 4(1):71-2. PubMed ID: 7951261
    [No Abstract]   [Full Text] [Related]  

  • 38. Biochemistry and genetics of Tay-Sachs disease.
    Gravel RA; Triggs-Raine BL; Mahuran DJ
    Can J Neurol Sci; 1991 Aug; 18(3 Suppl):419-23. PubMed ID: 1834320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tay-Sachs disease in an Israeli Arab family: Trp26-->stop in the alpha-subunit of hexosaminidase A.
    Drucker L; Navon R
    Hum Mutat; 1993; 2(5):415-7. PubMed ID: 8257995
    [No Abstract]   [Full Text] [Related]  

  • 40. Tay-Sachs disease heterozygote detection in Brazil: comparison between tears and leukocytes as beta-hexosaminidase A source.
    Buchalter MS; Wannmacher CM; Wajner M
    J Inherit Metab Dis; 1984; 7(1):35-7. PubMed ID: 6234430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.